Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2)

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has quickly spread around the globe. At present, there is no precise and effective treatment for the patients with COVID-19, so rapid development of drugs is urgently needed in order to contain the highl...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Yusen, Wang, Mengge, Chen, Hongzhuan, Chen, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349388/
https://www.ncbi.nlm.nih.gov/pubmed/34371003
http://dx.doi.org/10.1016/j.bcp.2021.114724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349388/
https://www.ncbi.nlm.nih.gov/pubmed/34371003
http://dx.doi.org/10.1016/j.bcp.2021.114724

Ejemplares similares